Mesa Science Associates Present at the National Institutes of Health CounterAct Meeting Held in Denver on June 13-15

FREDERICK, Md., June 21, 2018 /PRNewswire-PRWeb/ -- From June 13th to 15th 2018, Frederick Innovation Technology Center, Inc (FITCI) incubator/accelerator client Mesa Science Associates presented at The National Institutes of Health CounterACT meeting in Denver, CO.

Mike Mesa, Kenneth Dretchen and Matt Robben of Mesa Science Associates were co-authors on three scientific presentations presented at the annual National Institutes of Health CounterACT meeting held in Denver on June 13-15. These papers dealt with new and novel antidotes directed towards the treatment of cyanide and other compounds that interfere with cellular respiration. The papers are as follows:

Development of the Vitamin B12 Analog Cobinamide as a Hydrogen Sulfide Antidote. Chan A, Mukai D, Lee J, Burney T, Saber T, Saidan M, Mahon SB, Brenner M, Hendry-Hofer T, Witeof A, Bebarta V, Mesa M, Dretchen K, Robben M, Green C, Tubbs N, Cheung J, Haouzi and Boss G

Sodium Tetrathionate as a Cyanide Antidote. Chan A, Mukai D, Lee J, Burney T, Saber T, Saidan M, Mahon SB, Brenner M, Hendry-Hofer T, Witeof A, Bebarta V, Mesa M, Dretchen K, Robben M, Green C, and Boss G

A New Safer Cobinamide Formulation for Treating Cyanide Poisoning. Chan A, Mukai D, Lee J, Burney T, Saber T, Saidan M, Mahon SB, Brenner M, Hendry-Hofer T, Witeof A, Bebarta V, Mesa M, Dretchen K, Robben M, Dzisam J, Logue BA, and Boss G

FITCI CEO, Kathie Callahan Brady had this to say: "I am proud to have our clients and partners out and about in the community representing FITCI throughout the country. Mesa Science Associates are leaders in their field and we are excited to see them presenting at conferences around the world soon!"

For more information on Mesa Science Associates, their services or investment opportunities visit Mesa Science Associates at: http://www.mesascience.com

SOURCE Mesa Science Associates